Clinical Trial Update: Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intermittent oral vs semi-continuous intra-oral administration of levodopa/carbidopa in Parkinson disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa/Carbidopa (levodopa/carbidopa)

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED